Pulmonary balloon valvuloplasty in the palliation of complex cyanotic congenital heart disease

Heart

Volumn 76, Issue 4, 1996, Pages 363-366

  Stumper O ^a   Piechaud J F ^a   Bonhoeffer, P ^a   Bonnet, D ^a   Aggoun, Y ^a   Sidi, D ^a   Kachaner, J ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Congenital heart disease; Interventional catheterisation; Pulmonary stenosis; Pulmonary valvuloplasty

Indexed keywords

ADOLESCENT; ADULT; ARTERIAL PRESSURE; ARTICLE; BALLOON; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CYANOSIS; HUMAN; INFANT; NEWBORN; PALLIATIVE THERAPY; PRIORITY JOURNAL; STENOSIS; VALVULOPLASTY;

EID: 0029906603     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.76.4.363     Document Type: Article

References (12)

1. Kan JS, White RI, Mitchell SE, Gardner TJ. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary valve stenosis. N Engl J Med 1982;307: 540-5.
2. Rey C, Marache P, Francart C, Dupuis C. Percutaneous transluminal balloon valvuloplasty of congenital pulmonary valve stenosis, with a special report on infants and neonates. J Am Coll Cardiol 1988;11:815-20.
3. McCrindle BW for the VACA Registry Investigators. Independent predictors of long-term results after balloon pulmonary valvuloplasty. Circulation 1994;89:1751-9.
4. Qureshi SA, Kirk CR, Lamb RK, Arnold R, Wilkinson JL. Balloon dilatation of the pulmonary valve in the first year of life in patients with tetralogy of Fallot: a preliminary study. Br Heart J 1988;60:232-5.
5. Piéchaud JF, Delogu AB, Iserin L, Aggouh Y, Cohen L, Sidi D. Traitement palliatif de la tétralogie de Fallot par dilatation infundibulo-pulmonaire percutanée. Arch Mal Coeur 1994;87:573-9.
6. Sluysmans T, Neven B, Rubay J, Linkermans J, Ordest C, Mucurmbitsi J, et al. Early balloon dilatation of the pulmonary valve in infants with tetralogy of Fallot. Circulation 1995;91:1506-11.
7. Boucek MM, Webster HE, Orsmond GS, Ruttenberg HD. Balloon pulmonary valvotomy: palliation for cyanotic heart disease. Am Heart J 1988;115:318-22.
8. Kay PH, Capuani A, Franks R, Lincoln C. Experience with the modified Blalock-Taussig shunt using polytetrafluoroethylene grafts. Br Heart J 1983;49:359-63.
9. Bove EL, Kohman L, Sereika S, Byrum CJ, Kavey RW, BLackman MS, et al. The modified Blalock-Taussig shunt: analysis of the adequacy and duration of palliation. Circulation 1987;76(suppl III):19-23.
10. Frommelt MA, Frommelt PC, Berger S, Pelech AN, Lewis DA, Tweddell JS, et al. Does an additional source of pulmonary blood flow alter the outcome after a cavopulmonary shunt. Circulation 1995;92(suppl II):II-240-4.
11. Webber SA, Horvath P, LeBlanc JG, Slavik Z, Lamb RK, Monzo JL, et al. Influence of competitive pulmonary blood flow on the bidirectional superior cavopulmonary shunt. Circulation 1995;92(suppl II):279-86.
12. Uemura H, Yagihara T, Kawashima Y, Okada K, Kamiya T, Anderson RH. Use of the bidirectional Glenn procedure in the presence of forward flow from the ventricles to the pulmonary arteries. Circulation 1995;92(suppl II):228-32.